Augmented gastric inhibitory polypeptide response to intraduodenal glucose by exogenous gastrin and cholecystokinin.
D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology*; D004285:Dogs; D004386:Duodenum; D005215:Fasting; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism*; D005755:Gastrins / Q000494:pharmacology*; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000008:administration & dosage* / Q000494:pharmacology; D007263:Infusions, Parenteral; D010418:Pentagastrin / Q000494:pharmacology; D012633:Secretin / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology; D013268:Stimulation, Chemical
D005755:Gastrins; D005768:Gastrointestinal Hormones; D012633:Secretin; D012965:Sodium Chloride; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon; D002766:Cholecystokinin; D010418:Pentagastrin; D005947:Glucose